Mark D. Booth
Overview
Mark D. Booth received an average of $2M in total compensation, including $278K in salary, at Orexigen Therapeutics from 2009 to 2014.
2014Orexigen TherapeuticsChief Commercial Officer outgoing
2013Orexigen TherapeuticsChief Commercial Officer outgoing
2012Orexigen TherapeuticsChief Commercial Officer outgoing
2011Orexigen TherapeuticsChief Commercial Officer
2010Orexigen TherapeuticsChief Commercial Officer
2009Orexigen TherapeuticsChief Commercial Officer
Source: SEC filings on April 22, 2015, April 30, 2014, April 23, 2013, and April 27, 2012.
Related executives
We found 13 more executives who work or worked at Orexigen Therapeutics.
Michael Narachi
Orexigen Therapeutics
Chief Executive Officer
Thomas Cannell
Orexigen Therapeutics
Chief Operating Officer
Thomas Lynch
Orexigen Therapeutics
General Counsel
Joseph Hagan
Orexigen Therapeutics
Former Chief Business and Financial Officer
Preston Klassen
Orexigen Therapeutics
Executive Vice President, Global Product Development
Heather Turner
Orexigen Therapeutics
General Counsel
Graham Cooper
Orexigen Therapeutics
Chief Financial Officer
Dawn Viveash
Orexigen Therapeutics